Literature DB >> 14606219

Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing.

Susan E Levy1, Susan L Hyman.   

Abstract

Interventions considered to be CAM are in constant flux. New treatments emerge, older treatments become less popular, and the cycle recurs. Data supporting new treatments should be scrutinized for scientific study design, clinical safety, and scientific validity. Many families approach the clinician armed with brochures, handouts, and printouts from Web sites that are dedicated to the care and support of parents and children with ASD. A recent web search using "autism and detoxification" resulted in almost 8,000 sites. The Defeat Autism Now! (DAN!) Project arose in 1995 from collaboration of members of the Autism Research Institute. The DAN! Project advocates a specific and extensive protocol for diagnosis and treatment and can be viewed at http://www.autism.com/ari/#dan. The scientific validation and support for many interventions is incomplete and disparate from the recommendation in the American Academy of Pediatrics Policy Statement. Families should be encouraged to discuss all proposed investigations or treatments they wish to try with their primary care provider so the practitioner can serve as the medical home (Sidebar, page 688). The clinician should communicate and collaborate with the family and educational professionals to encourage objective identification of what works. With increasing access to health information and societal pressure for families to actively participate in their health management, continued growth of interest in CAM can be anticipated. Clinicians must remember that parents may have different beliefs regarding the effectiveness of treatment and different tolerance for treatment risks. Practitioners must keep avenues of communication open, remain open-minded, and not assume a "don't ask, don't tell" posture in the context of providing a medical home to the increasing number of children diagnosed with autism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14606219     DOI: 10.3928/0090-4481-20031001-10

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  18 in total

1.  Emergence of autism spectrum disorder in children from simplex families: relations to parental perceptions of etiology.

Authors:  Robin P Goin-Kochel; Sarah S Mire; Allison G Dempsey
Journal:  J Autism Dev Disord       Date:  2015-05

Review 2.  Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families.

Authors:  R Scott Akins; Kathy Angkustsiri; Robin L Hansen
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 3.  Complementary and alternative medicine in developmental disabilities.

Authors:  Kelly A Brown; Dilip R Patel
Journal:  Indian J Pediatr       Date:  2005-11       Impact factor: 1.967

4.  Parent health beliefs, social determinants of health, and child health services utilization among U.S. school-age children with autism.

Authors:  Katharine E Zuckerman; Olivia J Lindly; Brianna K Sinche; Christina Nicolaidis
Journal:  J Dev Behav Pediatr       Date:  2015-04       Impact factor: 2.225

5.  Use of Complementary and Alternative Medicine in Children with Autism Spectrum Disorders: A Multicenter Study.

Authors:  Ayhan Bilgiç; Ayhan Cöngöloğlu; Sabri Hergüner; Serhat Türkoğlu; Kayhan Bahali; Kağan Gürkan; İbrahim Durukan; Tümer Türkbay
Journal:  Noro Psikiyatr Ars       Date:  2013-09-01       Impact factor: 1.339

6.  Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study.

Authors:  Roger S Akins; Paula Krakowiak; Kathleen Angkustsiri; Irva Hertz-Picciotto; Robin L Hansen
Journal:  J Dev Behav Pediatr       Date:  2014-01       Impact factor: 2.225

7.  Parental perspectives on use, benefits, and physician knowledge of complementary and alternative medicine in children with autistic disorder and attention-deficit/hyperactivity disorder.

Authors:  Angela Huang; Kapila Seshadri; Tara Anne Matthews; Barbara M Ostfeld
Journal:  J Altern Complement Med       Date:  2013-04-26       Impact factor: 2.579

8.  A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.

Authors:  Benjamin L Handen; Raun D Melmed; Robin L Hansen; Michael G Aman; David L Burnham; Jon B Bruss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-01-16

9.  Parent Beliefs About the Causes of Learning and Developmental Problems Among Children With Autism Spectrum Disorder: Results From a National Survey.

Authors:  Katharine E Zuckerman; Olivia J Lindly; Brianna Sinche
Journal:  Am J Intellect Dev Disabil       Date:  2016-09

10.  Prevalence and Predictors of Complementary and Alternative Medicine Use in a Large Insured Sample of Children with Autism Spectrum Disorders.

Authors:  Ashli A Owen-Smith; Stephen Bent; Frances L Lynch; Karen J Coleman; Vincent M Yau; Kathryn A Pearson; Maria L Massolo; Virginia Quinn; Lisa A Croen
Journal:  Res Autism Spectr Disord       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.